维普中文期刊产品整合服务
538篇 您的检索式:作者名="MITSIADES"
    题名 作者 年代 出处 被引量
1An epigenomic approach to therapy for tamoxifen-resistant breast cancer显示文摘Tamoxifen 是为雌激素受体 alpha 的前线治疗(ERα) 在绝经前的女人的积极的胸肿瘤。然而,到 tamoxifen 的抵抗发生在许多病人。嗯仍然与获得的 tamoxifen 抵抗在乳癌房间的生长起一个关键作用,建议那 ERα为治疗仍然是一个有效目标 tamoxifen 抵抗(Tam-R ) 乳癌。以识别 ERα 的新奇管理者;发信号,通过对 histone 甲基修饰词的一幅小规模的 siRNA 屏幕,我们发现了 WHSC1, histone H3K36 methyltransferase, ERα 的一个积极管理者;在乳癌房间发信号。我们证明 WHSC1 被招募到 ERα由 BET 蛋白质 BRD3/4 的基因,并且便于 ERα基因表示。小分子的赌注蛋白质禁止者 JQ1 potently 压制了经典 ERα发信号的小径和在文化的 Tam-R 乳癌房间的生长。用一个 Tam-R 乳癌异种皮移植老鼠模型,我们与 JQ1 和 ER degrader fulvestrant 由 JQ1 和联合治疗的强壮的长持续的效果在 vivo 反胸癌症活动示威了。一起拿,我们提供 epigenomic 蛋白质 BRD3/4 和 WHSC1 是雌激素受体发信号的必要管理者并且是为 Tam-R 乳癌的治疗的新奇治疗学的目标的证据。Qin Feng Zheng Zhang Martin J Shea Chad J Creighton Cristian Coarfa Susan G Hilsenbeck Rainer Lanz Bin He Lei Wang Xiaoyong Fu Agostina Nardone Yongcheng Song James Bradner Nicholas Mitsiades Constantine S Mitsiades C Kent Osborne Rachel Schiff Bert W O'Malley 2014Cell Research2014,24,7:10
2Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control study显示文摘Maria Dalamaga Ilias Migdalis Jessica L. Fargnoli Evangelia Papadavid Erica Bloom Nicholas Mitsiades Konstantinos Karmaniolas Nicolaos Pelecanos Sofia Tseleni-Balafouta Amalia Dionyssiou-Asteriou Christos S. Mantzoros 2009Cancer Causes & Control2009,,5:3
3Integrative Genomic Profiling of Human Prostate Cancer显示文摘Barry S. Taylor Nikolaus Schultz Haley Hieronymus Anuradha Gopalan Yonghong Xiao Brett S. Carver Vivek K. Arora Poorvi Kaushik Ethan Cerami Boris Reva Yevgeniy Antipin Nicholas Mitsiades Thomas Landers Igor Dolgalev John E. Major Manda Wilson Nicholas D. 2010Cancer Cell2010,,:2
4Antimyeloma effi cacy of plitidepsin ( aplidin (R) ) : from bench to the bedside 显示文摘Ocio EM Mitsiades C Mateos MV 2007Blood2007,,:1
5Novel histone deacetylase inhibitors in the treatment of thyroid cancer显示文摘MITSIADES C S POULAKI V MCMULLAN C 2005Clin Cancer Res2005,15,:1
6Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves′ disease显示文摘Mitsiades N Poulaki V Tseleni Balafouta S 0,,:1
7VEGF-dependent conjunctivalization of the corneal surface 显示文摘JOUSSEN A M POULAKI V MITSIADES N 2003Invest Ophthalmol Vis Sci2003,44,1:1
8Thyroid carcinoma cells are resistant to FAS-mediatedd apoptosis but sensitibe to tumor necrosis factor-related apoptosis-inducing ligand显示文摘Mitsiades N Poulaki V Sophia TB 2000Cancer Res2000,60,15:1
9Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma :therapeutic applications 显示文摘Mitsiades N Mitsiades CS Poulaki V 2002Blood2002,99,11:1
10Regulation of vascular endothelial growth factor expression by insulin-like growth factorⅠin thyroid carcinomas显示文摘Poulaki V Mitsiades CS Mc Mullan C 2003J Clin Endocrinol Metab2003,88,11:1
11Molecular pathology of thyroid cancer: diagnostic and clinical implications 显示文摘Fagin JA Mitsiades N 2008Best Pract Res Clin En- docrinol Metab2008,22,6:1
12Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells : therapeutic implications 显示文摘Mitsiades N Mitsiades CS Poulaki V 2002Blood2002,99,12:1
13Bortezomib:proteasome inhibition as an effective anticancer therapy显示文摘Richardson PG Mitsiades C 2006Annu Rev Med2006,57,:1
14The proteasome inhibitor PS - 341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents 显示文摘Mitsiades N Mitsiades CS Richardson PG 2003Clin Cancer Res2003,9,3:1
15The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents:therapeutic applications显示文摘Mitsiades N Mitsiades C S Richardson PG 2003Blood2003,101,6:1
16VEGF-dependent eonjunetivalizafion of the corneal surface 显示文摘Joussen AM Poulaki V Mitsiades N 2003Invest Ophthalmol Vis Sei2003,44,1:1
17Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo显示文摘Joussen AM Poulaki V Qin W Kirchhof B Mitsiades N Wiegand SJ 2002Am J Pathol2002,160,2:1
18Regulation of Apo2L/tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in Thyroid Carcinoma Cells 显示文摘Poulaki V Mitsiades C S Kotoula V 2002Am J Pathol2002,161,:1
19显示文摘Mitsiades N Poulaki V Tseleni-Balafouia S 2000Thyroid2000,10,:1
20Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved intoa soluble form by a metalloproteinase 显示文摘Mitsiades N Piulaki V Kotoula V 1998Am J Pathol1998,153,6:1
返回顶部 每页显示:
共27页 首页 上一页 第1页 下一页 末页 /27 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费